Network Interview: Sesderma

Picture of Eva Sánchez Sáez
Eva Sánchez Sáez

21 Mar 2024

Sesderma is a dermatology laboratory founded in 1989 by Dr Gabriel Serrano. For more than 30 years, it has led the formulation and manufacture of cutting-edge dermocosmetic solutions, guaranteeing maximum efficacy and results. The company has always stayed ahead of the market thanks to its visionary and pioneering essence, making it a benchmark in the use of active ingredients and the most revolutionary encapsulation technology (Nanotech).

We discussed its track record, activity and constant commitment to innovation with Product Development Manager at Sesderma, Maite Badenas Biot:

 

AINIA Network and the SDGs

The Network Interviews series is developed within the framework of AINIA’s commitment to the Sustainable Development Goals (SDGs) promoted by the United Nations. We work to showcase our associated companies’ commitment to innovation, food safety and sustainability.

ODS9
Share this article
Picture of Eva Sánchez Sáez
Eva Sánchez Sáez

Técnico de comunicación

Contribuyo a dar visibilidad al conocimiento generado en proyectos de I+D+i, creando estrategias y contenidos que acercan la innovación tecnológica a la sociedad. Mi trabajo consiste en diseñar e implementar estrategias de comunicación que impulsan la visibilidad de iniciativas innovadoras, transmitiendo de forma rigurosa el valor de la investigación y la tecnología.

Interested in this topic?

Leave us your details and we will contact you to answer your questions or continue the conversation.

Eva Sánchez Sáez
Técnico de comunicación
Access to AINIA Network

This area is exclusive to AINIA Network members. If you are already a member, log in with your password. If not, you can request access.

Access to AINIA Network

This area is exclusive to AINIA Network members. If you are already a member, log in with your password. If not, you can request access.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.